November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Study Suggests Dimethyltryptamine May Enhance Donor Heart Recovery in Animal Model

🔬 Research 2 min read 👁 3

Researchers at Semmelweis University found that adding N,N-Dimethyltryptamine (DMT) to organ preservation solutions improved early hemodynamic performance in rat heart transplants. However, the work is limited to an early-stage animal model and requires further study before any clinical application can be considered.

🔬Research

Key points

  • Semmelweis University researchers tested DMT in a rat heart transplant model
  • Treated grafts showed improved systolic pressure and contractility
  • Research is strictly preclinical and requires further validation

Maintaining the viability of donor organs during cold storage remains a critical challenge in heart transplantation, as ischemia-reperfusion injury frequently compromises graft function. To explore potential protective measures, a team led by investigators at Semmelweis University in Budapest evaluated the effects of the endogenous compound N,N-Dimethyltryptamine (DMT) on donor heart recovery using a rat model of heterotopic heart transplantation.

During the study, donor hearts were preserved at low temperatures using a specialized solution either alone or supplemented with DMT, with treatment group donors and recipients also receiving the compound. Following transplantation, hemodynamic assessments revealed that the treated grafts achieved higher left ventricular systolic pressure, better myocardial contractility, and improved diastolic relaxation compared to untreated control organs. Molecular evaluations further indicated shifts in specific gene expressions and metabolic markers, though cardiac troponin I and inflammatory cytokine levels showed no significant differences.

What to know: While these findings suggest that DMT treatment may support early post-transplant cardiac performance under experimental conditions, the underlying mechanisms remain to be fully elucidated. Readers should note that this research was conducted exclusively in a laboratory animal model and does not constitute medical advice or establish safety in humans; always consult a qualified physician regarding personal health decisions.

The mechanisms underlying the observed functional improvement remain to be further elucidated.

Source Nature Health Sciences — nature.com/articles/s41598-026-77366-z ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.